Comparison of Mycophenolate Dosing Strategies in Pediatric Heart Transplant
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70422 ↗At a glance
Vergleichsstudie in Clinical Transplantation, 2026. Written by Dawn Y Nguyen and 5 co-authors. Institution: Department of Pharmacy, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Major MEDLINE topics: Heart Transplantation, Mycophenolic Acid, Immunosuppressive Agents, Graft Rejection. 16 references.
Abstract (original language)
Background
Mycophenolic acid (MPA) is a common immunosuppressant used in children post‐orthotopic heart transplant (OHT). Multiple MPA dosing strategies exist, with limited reports of comparisons between dosing strategies and patient outcomes.
Methods
We performed a retrospective review of heart transplant recipients ≤ 21 years from 2014 to 2022, comparing dose concordance and clinical outcomes of weight‐based mycophenolate dosing (15 mg/kg/dose every 12 h) to body surface area (BSA)‐based dosing (600 mg/m 2 /dose every 12 h).
Results
We analyzed 109 patients total (56% in the BSA‐based cohort and 44% in the weight‐based cohort). The BSA‐based cohort received a higher total milligram dose (480 (IQR 200–563) vs. 636 (IQR 320–1000), p = 0.005), mg/kg dose (14.5 (IQR 13.7–16.1) vs. 20.7 (IQR 16.4–25.8), p < 0.001) and mg/m 2 dose (382 (IQR 333–470) vs. 596 (IQR 572–612), p < 0.001) compared to the weight‐based cohort. The BSA‐based cohort experienced a lower hazard of rejection (HR 0.2, 95% CI 0.1–0.4 vs. weight‐based) and a greater hazard for overall infection (HR 2.2, 95% CI 1.2–3.9). There was no significant difference in 1‐year post‐transplant mortality and incidence of post‐transplant lymphoproliferative disorder (PTLD).
Conclusions
This study demonstrates the discordance between two common mycophenolate dosing strategies (1200 mg/m 2 /day vs. 30 mg/kg/day) and its resultant impact on pediatric heart transplant‐related outcomes. Further multicenter data would be useful to elucidate the impact on post‐heart transplant morbidity and mortality.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
- Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- Division of Cardiology, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
ORCID profiles: Dawn Y Nguyen, Anastacia Serluco, Justin K Chen, Gwen Nance, Zeling He, Arene Butto
Cite
APA
Nguyen, D. Y., Serluco, A., Chen, J. K., Nance, G., He, Z., & Butto, A. (2026). Comparison of Mycophenolate Dosing Strategies in Pediatric Heart Transplant. Clinical Transplantation. https://doi.org/10.1111/ctr.70422
Vancouver
Nguyen DY, Serluco A, Chen JK, Nance G, He Z, Butto A. Comparison of Mycophenolate Dosing Strategies in Pediatric Heart Transplant. Clinical Transplantation. 2026. doi:10.1111/ctr.70422
BibTeX
@article{Nguyen2026,
author = {Nguyen, Dawn Y and Serluco, Anastacia and Chen, Justin K and Nance, Gwen and He, Zeling and Butto, Arene},
title = {Comparison of Mycophenolate Dosing Strategies in Pediatric Heart Transplant},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70422}
}
EUVIMED